Can Constellation Brands’ Q2 Results Further Boost Its Stock?
Constellation Brands (STZ) is scheduled to announce its fiscal 2Q18 results on October 5, 2017. The quarter ended on August 31, 2017. As of September 28, 2017, STZ stock has risen an impressive 30.0% on a YTD (year-to-date) basis. The leading alcoholic beverages producer beat analysts’ earnings estimates in fiscal 1Q18 but slightly lagged the consensus sales estimate. The stock has risen 3.4% since the announcement of its fiscal 1Q18 results in June 2017.
Interested in STZ? Don't miss the next report.
Receive e-mail alerts for new research on STZ
YTD movement of peers
Constellation Brands stock has outperformed its major alcoholic beverage peers and the S&P 500 Index on a YTD basis. Anheuser-Busch InBev (BUD), Molson Coors Brewing (TAP), and Brown-Forman (BF.B) have returned 12.9%, -16.4%, and 21.1%, respectively, on a YTD basis. As of September 28, 2017, the S&P 500 Index has risen 12.1% since the start of 2017.
Constellation Brands is a leading producer and marketer of beer, wine, and spirits. The company has operations in the United States, Mexico, New Zealand, Italy, and Canada. Constellation Brands is the third-largest beer company in the United States. The company’s beer portfolio is comprised of high-end, popular imported beer brands such as Corona Extra, Corona Light, Modelo Especial, Modelo Negra, and Pacifico. The company’s beer portfolio includes craft beer brands Ballast Point and the recently acquired Funky Buddha Brewery.
Constellation Brands also has a strong presence in the premium wine category with brands such as Robert Mondavi, Clos du Bois, Kim Crawford, Meiomi, Mark West, Franciscan Estate, and The Prisoner. The company’s premium spirits portfolio includes Svedka Vodka, Casa Noble Tequila, and High West Whiskey.
In this earnings preview series on Constellation Brands, we’ll see what analysts expect from the company’s fiscal 2Q18 sales and earnings. We’ll also look at the company’s valuation and analysts’ ratings.
Let start by looking at analysts’ sales expectations.